Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Concepts in U.S. Food and Drug Administration Regulation of Artificial Intelligence for Medical Imaging
33
Zitationen
5
Autoren
2019
Jahr
Abstract
<b>OBJECTIVE.</b> Although extensive attention has been focused on the enormous potential of artificial intelligence (AI) technology, a major question remains: how should this fundamentally new technology be regulated? The purpose of this article is to provide an overview of the pathways developed by the U.S. Food and Drug Administration to regulate the incorporation of AI in medical imaging. <b>CONCLUSION.</b> AI is the new wave of innovation in health care. The technology holds promising applications to revolutionize all aspects of medicine.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.231 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.084 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.444 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.423 Zit.